The United States will begin participating in an international collaboration to distribute COVID-19 vaccines more equitably around the world after President Joe Biden reversed the Trump administration’s withdrawal from the World Health Organization on his first day in office. Richard Marlink, the director of Rutgers Global Health Institute, discusses the impact COVAX, the global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, will have on ending the COVID-19 pandemic and strengthening global health. To read the full story.
Recent Posts
- How Gender Bias Influences Math Education.
- Join NJ ACTS for Special Populations Seminar on 4/28 at 12pm
- Drug Metabolism Group Spring Symposium and Vendor Exhibition on May 5th
- Rutgers Health Begins Clinical Trial to Determine If B1 Can Slow Alzheimer’s Disease.
- Join NJACTS on 4/29 for a Multilingual Research Methods Workshop – Register by 4/22!
Categories
- Community (2,476)
- Covid (999)
- CTO Events (6)
- News (3,141)
- Pilots (21)